Holen Sie sich die Stockscreener-App
97.01
1.83%
-1.92
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$98.93
Offen:
$99.32
24-Stunden-Volumen:
9.10M
Relative Volume:
0.70
Marktkapitalisierung:
$240.79B
Einnahmen:
$63.90B
Nettoeinkommen (Verlust:
$19.05B
KGV:
12.83
EPS:
7.5596
Netto-Cashflow:
$13.05B
1W Leistung:
-3.87%
1M Leistung:
+12.56%
6M Leistung:
+22.43%
1J Leistung:
-6.43%
1-Tages-Spanne:
$96.06
$99.85
1-Wochen-Bereich:
$96.06
$103.09
52-Wochen-Spanne:
$73.31
$105.84
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Vergleichen Sie MRK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
97.02 | 245.55B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
LLY
Lilly Eli Co
|
991.74 | 892.86B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
201.59 | 485.76B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
223.37 | 394.34B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
132.13 | 249.77B | 54.45B | 14.42B | 17.15B | 7.333 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-10-13 | Fortgesetzt | Citigroup | Neutral |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Drugmakers Briefed As Vaccine Skeptics Like RFK Jr. Probe RSV Therapy Risks - Benzinga
Investment Management Corp of Ontario Boosts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stake Cut by State Street Corp - MarketBeat
Fayez Sarofim & Co Sells 296,666 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stake Boosted by Daiwa Securities Group Inc. - MarketBeat
Axa S.A. Sells 13,668 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. Sees Unusually High Options Volume (NYSE:MRK) - MarketBeat
SVB Wealth LLC Lowers Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Ossiam - MarketBeat
Gabelli Funds LLC Trims Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Jim Cramer on Merck: “The People Who Run This Company Are Not Idiots” - Yahoo Finance Singapore
California Public Employees Retirement System Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
48,678 Shares in Merck & Co., Inc. $MRK Acquired by Stenger Family Office LLC - MarketBeat
Cheviot Value Management LLC Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Cresset Asset Management LLC Has $21.75 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Epoch Investment Partners Inc. Has $57.05 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Brown Advisory Inc. Sells 22,392 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck (NYSE:MRK) S&P 500 Companies Power Drug Progress - Kalkine Media
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 1.1%Here's Why - MarketBeat
Trek Financial LLC Decreases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
M Holdings Securities Inc. Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Kennedy Capital Management LLC - MarketBeat
Guggenheim Adjusts Price Target on Merck & Co. to $122 From $104, Maintains Buy Rating - marketscreener.com
Amundi Buys 3,454,941 Shares of Merck & Co., Inc. $MRK - MarketBeat
Beutel Goodman & Co Ltd. Acquires 679,339 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Trading Down 1.4%What's Next? - MarketBeat
Merck & Co. Closes $7 Billion Notes Offering - TipRanks
Merck & Co., Inc. (MRK) Stock: Gains FDA Nod for New Cattle Antiparasitic - CoinCentral
Scotiabank Issues Positive Forecast for Merck & Co., Inc. (NYSE:MRK) Stock Price - MarketBeat
FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment - pharmiweb.com
Merck & Co., Inc. (MRK): A Bull Case Theory - Insider Monkey
FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis) - Business Wire
Scotiabank Adjusts Price Target on Merck & Co to $120 From $105, Maintains Sector Outperform Rating - marketscreener.com
Panagora Asset Management Inc. Sells 770,925 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Guggenheim Capital LLC - MarketBeat
First Trust Advisors LP Has $399.74 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
CW Advisors LLC Reduces Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Baird Financial Group Inc. - MarketBeat
1832 Asset Management L.P. Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Up 1.3% on Analyst Upgrade - MarketBeat
Analysts Conflicted on These Healthcare Names: Merck & Company (MRK), Alibaba Health Information Technology (OtherALBHF) and Janux Therapeutics Inc (JANX) - The Globe and Mail
River Wealth Advisors LLC Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Invesco Ltd. Has $1.35 Billion Stake in Merck & Co., Inc. $MRK - MarketBeat
US58933YCB9 Bond Price and Chart — MUN:US58933YCB9 - TradingView
Merck (MRK) Stock on December 2, 2025: Dividend Hike, FDA Wins and Fresh Wall Street Targets - ts2.tech
The Goldman Sachs Group Boosts Merck & Co., Inc. (NYSE:MRK) Price Target to $120.00 - MarketBeat
Transcript : Merck & Co., Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-02-2025 09 - marketscreener.com
Westerkirk Capital Inc. Makes New $2.64 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Isthmus Partners LLC Makes New $1.03 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Sio Capital Management LLC Has $13.77 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
M&T Bank Corp Decreases Position in Merck & Co., Inc. $MRK - MarketBeat
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.49%
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):